Lys35
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.0.1
Powered by Cell Signaling Technology
Home > Sumoylation Site Page: > Lys35  -  MAF1 (human)

Site Information
RIESYSCkMAGDDKH   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 31094506

In vivo Characterization
Methods used to characterize site in vivo:
mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
brain cancer ( 1 ) , glioblastoma ( 1 ) , glioma ( 1 )
Relevant cell line - cell type - tissue:

Downstream Regulation
Effects of modification on MAF1:
molecular association, regulation ( 1 )
Effects of modification on biological processes:
cell growth, inhibited ( 1 ) , transcription, inhibited ( 1 )
Induce interaction with:
POLR3A (human) ( 1 )

References 

1

Rohira AD, Chen CY, Allen JR, Johnson DL (2013) Covalent Small Ubiquitin-like Modifier (SUMO) Modification of Maf1 Protein Controls RNA Polymerase III-dependent Transcription Repression. J Biol Chem 288, 19288-95
23673667   Curated Info